Showing results (81-90 of 155) with videos related to
Sort By:
Pageof 16
The Australian & New Zealand Journal of Obstetrics & Gynaecology|December 6, 2017
Clinician factors associated with prescribing nicotine replacement therapy in pregnancy: A cross-sectional survey of Australian obstetricians and general practitionersYael Bar-Zeev, Billie Bonevski, Maree Gruppetta, et al.Biochemical and Biophysical Research Communications|February 1, 2006
Expansion and redifferentiation of adult human pancreatic islet cellsLimor Ouziel-Yahalom, Michal Zalzman, Leeat Anker-Kitai, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 28, 2014
Time trends of viral meningitis among young adults in Israel: 1978-2012Hagai Levine, Daniel Mimouni, Anat Zurel-Farber, et al.Breast Cancer Research and Treatment|April 10, 2026
Neoadjuvant twelve weekly paclitaxel-carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancerYasmin Leshem, Inbal Golomb, Asia Zubkov, et al.Addictive Behaviors|July 31, 2026
Beliefs about the relative harmfulness of electronic cigarettes compared with cigarettes among adults: findings from the ITC Israel SurveyVicki Myers, Yael Bar-Zeev, David Steinberg, et al.Appetite|January 24, 2025
Feasibility, acceptability and preliminary effectiveness of a manualized lay-led food literacy intervention for women in a community settingKeren L Greenberg, Yael Bar-Zeev, Milka Donchin, et al.Transplantation and Cellular Therapy|August 17, 2023
Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized TrialRon Ram, Odelia Amit, Amos Adler, et al.Breast Cancer Research and Treatment|June 22, 2026
Efficacy and toxicity of neoadjuvant chemotherapy versus chemo-immunotherapy in triple-negative breast cancer patients with and without germline BRCA mutationsTal Etan, Lior Cohen, Yael Bar, et al.Breast Cancer Research and Treatment|February 14, 2024
Searching for the "Holy Grail" of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA)Lucy Gao, Arielle Medford, Laura Spring, et al.Tobacco Control|November 23, 2022
PMI's IQOS and cigarette ads in Israeli media: a content analysis across regulatory periods and target population subgroupsAmal Khayat, Carla J Berg, Hagai Levine, et al.Pageof 16